Burning Rock Biotech Ltd.-ADRBNR
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 17 institutions reported holding Burning Rock Biotech Ltd.-ADR (BNR) in their 13F filings, down 1 from Q1 2025. 1 opened new positions and 2 sold out. The largest holders were Kynam Capital Management, LP ($3.1M), CRCM LP ($615K) and Amova Asset Management Americas, Inc. ($141K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Burning Rock Biotech Ltd.-ADR
- CUSIP
- 12233L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $77K |
| Exits | 2 | $1.8M |
All 13F filers, Q1 2025 → Q2 2025: 32,631 shares bought and 791,415 shares sold, net −758,784 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Kynam Capital Management, LP | 0.34% | No change | 994,883 | $3.1M |
| CRCM LP | 0.18% | Reduce -13.9% | 194,766 | $615K |
| Amova Asset Management Americas, Inc. | 0.00% | No change | 43,928 | $141K |
| Sumitomo Mitsui Trust Group, Inc. | 0.00% | No change | 43,928 | $139K |
| Renaissance Technologies | 0.00% | No change | 31,717 | $100K |
| Massachusetts Financial Services Co. | 0.00% | Reduce -91.7% | 30,814 | $97K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 29,278 | $93K |
| Citadel Advisors | 0.00% | New | 24,451 | $77K |
| HSG Holding Ltd | 0.00% | No change | 21,212 | $67K |
| Morgan Stanley | 0.00% | Add +69.8% | 18,207 | $58K |
| SkyView Investment Advisors, LLC | 0.00% | No change | 10,000 | $32K |
| BNP Paribas Financial Markets | 0.00% | Add +12.5% | 900 | $3K |
| Shen Neil Nanpeng | 100.00% | No change | 885 | $3K |
| UBS Group AG | 0.00% | Add +544.5% | 709 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -57.5% | 51 | $161 |
| Rhumbline Advisers | 0.00% | Reduce -20.7% | 23 | $72 |
| BlackRock, Inc. | 0.00% | No change | 10 | $32 |
"% of holder's portfolio" is BNR's weight in each manager's 13F, not the share of Burning Rock Biotech Ltd.-ADR the manager owns.